Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a transfer :

Similar documents
Acute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)

Level III Stroke Center Data Collection Requirements

UPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK

UMHS In-Patient Acute Ischemic Stroke Treatment Guidelines*

TPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD

Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient

EMS Management of Stroke. Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D.

REGIONAL SUSPECTED STROKE PROTOCOL

Protocol: Initial Evaluation and Management of Patients with Ischemic or Hemorrhagic Stroke

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center

ACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued)

4/24/2015. Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department. Learning Objectives.

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

The Clinical Evaluation of the Comatose Patient in the Emergency Department

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

Guidelines and Protocols

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

DIAGNOSTIC CRITERIA OF STROKE

AR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.

Managed Clinical Network for Stroke Stroke Unit Protocol/Guideline

Dabigatran (Pradaxa) Guidelines

Building an Emergency Response to Acute Stroke

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Approved: Acute Stroke Ready Hospital Advanced Certification Program

Global Objectives. Use of the NIH Stroke Scale (NIHSS) in Emergency Department Patients with Acute Stroke. Why Do This Exercise? Session Objectives

STATEMENT OF STANDARD

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

NOVEL ANTICOAGULANTS

DVT/PE Management with Rivaroxaban (Xarelto)

The author has no disclosures

King County EMS Stroke Quality Improvement Program

Basic Stroke for the New Recruit

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Acute Ischemic Stroke with tpa

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Is this pt s brain dysfunction due to ischemia? Onset & progression of sx; location of deficit

Appendix L: HQO Year 1 Implementation Priorities

A Collaborative Effort to Improve Emergency Stroke Care: Mobile Stroke Unit

Critical Bleeding Reversal Protocol

STROKE OCCURRENCE SYMPTOMS OF STROKE

Emerging therapies for Intracerebral Hemorrhage

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Stroke Transfers. Downstate Receiving Hospital Perspective

JHS Stroke Program JHS Annual Mandatory Education

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Stroke Care First week

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

STROKE TRAINING FOR EMS PROFESSIONALS

Stroke Thrombolysis Awareness. Initial patient assessment. Using F.A.S.T., Rosier, & NIHSS Tools

E x p l a i n i n g Stroke

Ischemic Stroke Clinical Pathway

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Novel oral Anticoagulants, stroke and intracerebral hemorrhage

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Stroke Receiving Facility Toolkit

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

Disclosures. Georgia Facts. Stroke System Models. Telestroke. The World is Flat : A Brief Future of Acute Stroke Care

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Anticoagulants in Atrial Fibrillation

Let s talk about: Stroke

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Providence Brain Institute Providence Portland Medical Center

Anticoagulation before and after cardioversion; which and for how long

AHA/ASA Guideline. The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

Malmö Preventive Project. Cardiovascular Endpoints

Slumping, Slurring and Slipping Away: Stroke Assessment. Laurie A. Romig, MD, FACEP Medical Director Pinellas County (FL) EMS

CASE STUDIES ON ACUTE STROKE TREATMENT

convey the clinical quality measure's title, number, owner/developer and contact

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Ischaemic stroke 85% (85 in every 100 strokes)

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Long term care coding issues for ICD-10-CM

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

Anticoagulation For Atrial Fibrillation

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

The management of cerebral hemorrhagic complications during anticoagulant therapy

What Is an Arteriovenous Malformation (AVM)?

Stroke And Multiple Sclerosis ACOI Internal Medicine Review Course Scott Spradlin D.O. FACOI

STARTING, SWITCHING OR STOPPING NEW ORAL ANTICOAGULANTS: A Practical Approach

Anticoagulants. Anticoagulants Definition. When are blood clots GOOD? Where and why do blood clots occur? 6/12/2014

Primary Stroke Certification

High Risk Emergency Medicine

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

PE finding: Left side extremities mild weakness No traumatic wound No bloody otorrhea, nor rhinorrhea

Treatment of Ischemic Stroke in the Neuro-ICU

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Transcription:

When to Consider a transfer : Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma NIHSS 4 Ischemic Stroke Signs & sympoms consistent with large vessel occlusion ( Drip and Ship ) Hunt Hess Score 3 Stroke in the young (<55 years of age) Rapidly declining mental status, espcially requiring intubation To Transfer a stroke patient: If the patient is not admitted to your hospital then call the Alabama Trauma Communications Center (ATCC) at 1-800- 359-0123 to arrange transfer for the potential stroke or stroke patient. Community hospitals in region 5 that are not a stroke hospital of any level can also utilize the ATCC to transfer patients to Level 2 or Level 3 hospitals. If the patient is admitted to your hospital, then this will be a hospital to hospital transfer. Call Baptist Medical Center South at 334-288-2100 and have the admitting physician ask for the on-call neurologist to discuss the patient s case. http://baptistfirst.org/services/stroke-center/default.aspx The Golden Hour Page 1 of 7 8/2014

When preparing to transfer an acute stroke patient to Baptist Medical Center South s Primary Stroke Center, please make every attempt to include the following information while awaiting EMS. *However, do not delay transfer. Results of all diagnostic testing performed including lab results and imaging exams (See attached Radiology Images from Outside Facilities form) NIH Stroke Scale documentation to assess improvement or decline upon arrival to Baptist Medical Center South Time of symptom onset and source of this information Contact information of family members (Cell phone if available) Pertinent elements of patient s past medical history, especially atrial fibrillation, warfarin therapy, congestive heart failure, diabetes, prior strokes, prior intracerebral hemorrhage, recent surgeries or instrumentation, and trauma Patient s current medication list Brief documentation of ALL therapies initiated at your hospital If IV tpa is excluded, please document rationale In no circumstances should acquisition of these items delay the transfer of the patient. Urgent transfer maximizing treatment within the golden hour is an absolute priority. Page 2 of 7 8/2014

1. Patient Name: Date: 2. Information/ history from: ( ) Patient ( ) Family member (authorized to give consent) Name: Phone: 3. Last Known time patient was at baseline or deficit free and awake: Time: Date: TIME OF SYMPTOM ONSET: AM PM STROKE TEAM ACTIVATION CRITERIA YES UNKNOWN NO 4. Symptom duration less than 4.5 hours ( ) ( ) ( ) 5. Blood glucose between 60 and 400 ( ) ( ) ( ) If Yes is answered to # 4&5, begin transfer process then complete remaining while awaiting EMS arrival 6. OBVIOUS ASYMMETRY Normal Right Facial: smile/grimace ( ) ( ) Absent/Lax ( ) Absent/Lax Grip ( ) ( ) Weak ( ) No grip ( ) Weak ( ) No grip Arm drift ( ) ( ) Drifts down ( ) Falls rapidly ( ) Drifts down ( ) Falls rapidly Based on exam, patient has only unilateral (not bilateral) weakness: Yes ( ) No ( ) 7. Language Appropriate Inappropriate Able to repeat sentence ( ) ( ) Able to name objects (pen, watch) ( ) ( ) Speech clarity (evaluate for slurring) ( ) ( ) Based on assessment, patient has new onset language/ orientation deficit Yes ( ) No ( ) 8. Items 4-7 all Yes (or unknown)=stroke Team Activation criteria met Yes ( ) No ( ) Onset of symptoms plus transport time <4.5 hours Yes ( ) No ( ) Left In no circumstances should acquisition of these items delay the transfer of the patient. Urgent transfer maximizing treatment within the golden hour is an absolute priority. Page 3 of 7 8/2014

Transfer Algorithm Patient with sudden onset of stroke symptoms Positive F-A-S-T Facial droop, Arm weakness/drift, Speech disturbance, Time of symptom onset Glucose within 60-400 Glucose < 60 or > 400 Treat symptoms per your hospital s policy and continue to monitor patient Establish time pt. last seen normal/ time of symptom onset If symptom onset < 3 hours or if up to 4.5 hours with four additional exclusion criteria and F-A-S-T positive: o Prepare for transfer to Baptist Medical Center South Additional Exclusion Criteria *While waiting for EMS, complete the following: Stat non-contrast Brain CT Start two large bore IVs or verify IVs are patent Obtain PT/INR, PTT, CBC, CMP Obtain 12 lead EKG Check VS every 15 minutes o Maintain BP SBP <185 and DBP <110 Complete NIH Stroke Scale, if able Keep patient NPO until swallow screen completed and passed and/or Speech Therapist evaluation 1. Older than 80 years of age 2. On anticoagulant regardless of INR 3. Severe Stroke deficits (NIHSS >25) 4. Medical history of stroke and diabetes The ED MD or Admitting MD to discuss patient s case with on-call neurologist at 334-288-2100. Discussion should determine the administration of Activase, aka tpa, - will it be administered at patient s current location then transfer ( drip & ship ) or transfer patient to have tpa administered at Baptist Medical Center South. Refer to Pre/During/Post tpa administration blood pressure frequency and parameters and neuro check frequency In no circumstances should acquisition of these items delay the transfer of the patient. Urgent transfer maximizing treatment within the golden hour is an absolute priority. Page 4 of 7 8/2014

Inclusion and exclusion characteristics of patients within 3 hours from stroke symptom onset: Inclusion criteria Diagnosis of ischemic stroke causing measurable neurological deficit Onset of symptoms <3 hours before beginning treatment Aged 18 years Exclusion criteria Significant head trauma or prior stroke in previous 3 months Symptoms suggest subarachnoid hemorrhage Arterial puncture at noncompressible site in previous 7 days History of previous intracranial hemorrhage Intracranial neoplasm, arteriovenous malformation, or aneurysm Recent intracranial or intraspinal surgery Elevated blood pressure (systolic > 185 mmhg or diastolic > 110 mmhg) Active internal bleeding Acute bleeding diathesis, including but not limited to Platelet count < 100000/mm3 Heparin received within 48 hours, resulting in abnormally elevated aptt greater than the upper limit of normal Current use of anticoagulant with INR >1.7 or PT>15 seconds Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory test (such as aptt, INR, platelet count, and ECT; TT; or appropriate factor Xa activity assays) Blood glucose concentration <50 mg/dl (2.7 mmol/l) CT demonstrates multilobar infarction (hypodensity >1/3 cerebral hemisphere) Relative exclusion criteria Recent experience suggests that under some circumstances- with careful consideration and weighing of risk to benefitpatients may receive fibrinolytic therapy despite 1 or more relative contraindications. Consider risk to benefit of IV rtpa administration carefully if any of these relative contraindications are present: Only minor or rapidly improving stroke symptoms (clearing spontaneously) Pregnancy Seizure at onset with postictal residual neurological impairments Major surgery or serious trauma within previous 14 days Recent gastrointestinal or urinary tract hemorrhage (within previous 21 days) Recent acute myocardial infarction (within previous 3 months) Page 5 of 7 8/2014

Pre tpa Administration Verify the following prior to administration: measured weight, t-pa inclusion/exclusion criteria documented, informed consent has been obtained Baseline Blood Pressure (pre-tpa bolus): Use manual BP cuff and check bilateral arm BP o Notify neurologist immediately for BP treatment order if any of the following occur: SBP 185mmHg, DBP 110mmHg, > 30mmHg difference in SBP between arms, and/or if unable to use one arm Documentation of baseline BP/ Document reason if BP could not be checked in one arm BP Right Arm / BP Left Arm / During tpa administration Maintain Blood Pressure 160-180/90-105- Notify Neurologist immediately if not within this range and change in neurological status Time of tpa bolus (give over 1 minute): Time tpa infusion started (infuse over 1hr): Document vital signs (Manual BP, HR, and RR) and Neuro Checks Q15 min x 4 1. BP / ; HR ; RR & Neuro check 2. BP / ; HR ; RR & Neuro check 3. BP / ; HR ; RR & Neuro check 4. BP / ; HR ; RR & Neuro check Post tpa administration Maintain Blood Pressure 160-180/90-105- Notify Neurologist immediately if not within this range and change in neurological status Document vital signs (Manual BP, HR, and RR) and Neuro checks Q 15 minutes x4 then Q 30minutes x 6 hours then Q 1 hour x 16 hours NIHSS should be completed pre and post tpa administration & then 24 hours from bolus Verify Non-contrast CT Brain is ordered 24 hours from tpa bolus Page 6 of 7 8/2014

Page 7 of 7 8/2014